- Home
- PYPD vs FMST Comparison
PYPD vs FMST Comparison
Compare PYPD & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- FMST
- Stock Information
- Founded
- PYPD 2008
- FMST 2005
- Country
- PYPD Israel
- FMST Canada
- Employees
- PYPD N/A
- FMST N/A
- Industry
- PYPD Medical/Dental Instruments
- FMST Other Metals and Minerals
- Sector
- PYPD Health Care
- FMST Basic Materials
- Exchange
- PYPD Nasdaq
- FMST Nasdaq
- Market Cap
- PYPD 36.0M
- FMST 39.6M
- IPO Year
- PYPD 2020
- FMST N/A
- Fundamental
- Price
- PYPD $3.66
- FMST $2.42
- Analyst Decision
- PYPD Strong Buy
- FMST
- Analyst Count
- PYPD 5
- FMST 0
- Target Price
- PYPD $11.40
- FMST N/A
- AVG Volume (30 Days)
- PYPD 175.1K
- FMST 376.8K
- Earning Date
- PYPD 08-13-2025
- FMST 01-01-0001
- Dividend Yield
- PYPD N/A
- FMST N/A
- EPS Growth
- PYPD N/A
- FMST N/A
- EPS
- PYPD N/A
- FMST N/A
- Revenue
- PYPD N/A
- FMST N/A
- Revenue This Year
- PYPD N/A
- FMST N/A
- Revenue Next Year
- PYPD N/A
- FMST N/A
- P/E Ratio
- PYPD N/A
- FMST N/A
- Revenue Growth
- PYPD N/A
- FMST N/A
- 52 Week Low
- PYPD $2.30
- FMST $0.55
- 52 Week High
- PYPD $4.42
- FMST $5.74
- Technical
- Relative Strength Index (RSI)
- PYPD 65.03
- FMST 39.09
- Support Level
- PYPD $3.30
- FMST $2.32
- Resistance Level
- PYPD $3.87
- FMST $2.89
- Average True Range (ATR)
- PYPD 0.14
- FMST 0.27
- MACD
- PYPD 0.01
- FMST -0.11
- Stochastic Oscillator
- PYPD 86.84
- FMST 8.70
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.